Condition: Advanced Melanoma · Sponsor: Replimune, Inc.
This is a randomized, controlled, multicenter, open-label Phase 3 clinical study comparing VO in combination with nivolumab versus Physician's Choice treatment for patients with unresectable Stage IIIb-IV cutaneous melanoma whose disease progressed on an anti PD-1 and an anti-CTLA-4 containing regimen (administered either as a combination regimen or in sequence) or who are not candidates for treatment with an anti-CTLA-4 therapy.
This description comes directly from the study's public registry record.
Clinical Trials at Replimune · 1-781-222-9570 · clinicaltrials@replimune.com
Always discuss trial participation with your own doctor first.
| Banner MD Anderson Cancer Center | Gilbert, Arizona, United States | Recruiting |
| UC San Diego Moores Cancer Center | La Jolla, California, United States | Recruiting |
| The Angeles Clinic and Research Institute | Los Angeles, California, United States | Recruiting |
| USC Norris Comprehensive Cancer Center | Los Angeles, California, United States | Recruiting |
| UCLA Department of Medicine - Hematology/Oncology | Los Angeles, California, United States | Recruiting |
| UC Irvine Health, Chao Family Comprehensive Cancer Center | Orange, California, United States | Recruiting |
| Stanford Cancer Institute | Palo Alto, California, United States | Recruiting |
| Sutter Medical Group | Sacramento, California, United States | Withdrawn |
| San Francisco Oncology Associates | San Francisco, California, United States | Recruiting |
| UCSF Helen Diller Family Comprehensive Cancer Center | San Francisco, California, United States | Recruiting |
| University of Colorado Hospital - Anschutz Cancer Pavilion | Aurora, Colorado, United States | Recruiting |
| The Melanoma and Skin Cancer Institute | Englewood, Colorado, United States | Recruiting |
+ 69 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06264180